Salpep Biotechnology Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Salpep Biotechnology General Information

Description

Developer of novel anti-inflammatory molecules as therapeutic agents. The company discovers and develops anti-inflammatory therapeutic agents for treating asthma and intestinal motility disturbances caused by allergic and endotoxemic reactions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 3330 Hospital Drive Northwest
  • Calgary, Alberta
  • Canada
+1 (403)
Primary Industry
Drug Discovery
Acquirer
AtheroMedix
Vertical(s)
Corporate Office
  • 3330 Hospital Drive Northwest
  • Calgary, Alberta
  • Canada
+1 (403)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salpep Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Salpep Biotechnology‘s full profile, request access.

Request a free trial

Salpep Biotechnology Patents

Salpep Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2642849-A1 Suppression and treatment of neuropathic pain Inactive 30-Mar-2006
EP-1998791-A1 Suppression and treatment of neuropathic pain Inactive 30-Mar-2006
EP-1998791-A4 Suppression and treatment of neuropathic pain Inactive 30-Mar-2006
JP-2009531335-A Suppression and treatment of neuropathic pain Pending 30-Mar-2006
WO-2007112556-A1 Suppression and treatment of neuropathic pain Inactive 30-Mar-2006 A61K38/05
To view Salpep Biotechnology’s complete patent history, request access »

Salpep Biotechnology Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Salpep Biotechnology‘s full profile, request access.

Request a free trial

Salpep Biotechnology FAQs

  • When was Salpep Biotechnology founded?

    Salpep Biotechnology was founded in 1996.

  • Where is Salpep Biotechnology headquartered?

    Salpep Biotechnology is headquartered in Calgary, Canada.

  • What industry is Salpep Biotechnology in?

    Salpep Biotechnology’s primary industry is Drug Discovery.

  • Is Salpep Biotechnology a private or public company?

    Salpep Biotechnology is a Private company.

  • What is Salpep Biotechnology’s current revenue?

    The current revenue for Salpep Biotechnology is .

  • How much funding has Salpep Biotechnology raised over time?

    Salpep Biotechnology has raised $659K.

  • Who are Salpep Biotechnology’s investors?

    MedInnova Partners, Milestone Medica, and University Medical Discoveries have invested in Salpep Biotechnology.

  • When was Salpep Biotechnology acquired?

    Salpep Biotechnology was acquired on 01-Mar-2007.

  • Who acquired Salpep Biotechnology?

    Salpep Biotechnology was acquired by AtheroMedix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process